{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:07:01Z","timestamp":1793506021598,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40360-017-0169-y","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T11:45:17Z","timestamp":1504093517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation"],"prefix":"10.1186","volume":"18","author":[{"given":"Yun Hyi","family":"Ku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Jun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak C.","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"issue":"6423","key":"169_CR1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","volume":"362","author":"R Ross","year":"1993","unstructured":"Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362(6423):801\u20139.","journal-title":"Nature"},{"issue":"2","key":"169_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340(2):115\u201326.","journal-title":"N Engl J Med"},{"issue":"9A","key":"169_CR3","doi-asserted-by":"crossref","first-page":"11I","DOI":"10.1016\/S0002-9149(97)00793-5","volume":"80","author":"S Kinlay","year":"1997","unstructured":"Kinlay S, Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol. 1997;80(9A):11I\u20136I.","journal-title":"Am J Cardiol"},{"issue":"6801","key":"169_CR4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","volume":"407","author":"AJ Lusis","year":"2000","unstructured":"Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233\u201341.","journal-title":"Nature"},{"issue":"4","key":"169_CR5","first-page":"317","volume":"25","author":"S Irie","year":"1991","unstructured":"Irie S, Tavassoli M. Transendothelial transport of macromolecules: the concept of tissue-blood barriers. Cell Biol Rev. 1991;25(4):317\u201333. 340-311","journal-title":"Cell Biol Rev"},{"issue":"3","key":"169_CR6","doi-asserted-by":"crossref","first-page":"L419","DOI":"10.1152\/ajplung.2000.279.3.L419","volume":"279","author":"T Stevens","year":"2000","unstructured":"Stevens T, Garcia JG, Shasby DM, Bhattacharya J, Malik AB. Mechanisms regulating endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol. 2000;279(3):L419\u201322.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3 Pt 1","key":"169_CR7","first-page":"L223","volume":"267","author":"H Lum","year":"1994","unstructured":"Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Phys. 1994;267(3 Pt 1):L223\u201341.","journal-title":"Am J Phys"},{"issue":"2","key":"169_CR8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C","volume":"173","author":"I Flamme","year":"1997","unstructured":"Flamme I, Frolich T, Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol. 1997;173(2):206\u201310.","journal-title":"J Cell Physiol"},{"issue":"23","key":"169_CR9","doi-asserted-by":"crossref","first-page":"16349","DOI":"10.1074\/jbc.274.23.16349","volume":"274","author":"Y Fujio","year":"1999","unstructured":"Fujio Y, Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem. 1999;274(23):16349\u201354.","journal-title":"J Biol Chem"},{"issue":"3","key":"169_CR10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0014-5793(00)01657-4","volume":"477","author":"S Dimmeler","year":"2000","unstructured":"Dimmeler S, Dernbach E, Zeiher AM. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett. 2000;477(3):258\u201362.","journal-title":"FEBS Lett"},{"issue":"4","key":"169_CR11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.ATV.20.4.1006","volume":"20","author":"Y Rikitake","year":"2000","unstructured":"Rikitake Y, Kawashima S, Yamashita T, Ueyama T, Ishido S, Hotta H, Hirata K, Yokoyama M. Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway. Arterioscler Thromb Vasc Biol. 2000;20(4):1006\u201312.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"169_CR12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.RES.86.1.4","volume":"86","author":"S Dimmeler","year":"2000","unstructured":"Dimmeler S, Zeiher AM. Akt takes center stage in angiogenesis signaling. Circ Res. 2000;86(1):4\u20135.","journal-title":"Circ Res"},{"issue":"9","key":"169_CR13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1091\/mbc.4.9.953","volume":"4","author":"JE Meredith Jr","year":"1993","unstructured":"Meredith JE Jr, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell. 1993;4(9):953\u201361.","journal-title":"Mol Biol Cell"},{"key":"169_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1749-6632.1997.tb51986.x","volume":"811","author":"E Dejana","year":"1997","unstructured":"Dejana E, Valiron O, Navarro P, Lampugnani MG. Intercellular junctions in the endothelium and the control of vascular permeability. Ann N Y Acad Sci. 1997;811:36\u201343. discussion 43-34","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"169_CR15","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1210\/en.2003-0288","volume":"144","author":"CH Lee","year":"2003","unstructured":"Lee CH, Olson P, Evans RM. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology. 2003;144(6):2201\u20137.","journal-title":"Endocrinology"},{"issue":"4","key":"169_CR16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1097-2765(00)80210-5","volume":"4","author":"N Kubota","year":"1999","unstructured":"Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4(4):597\u2013609.","journal-title":"Mol Cell"},{"issue":"4","key":"169_CR17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","volume":"4","author":"Y Barak","year":"1999","unstructured":"Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999;4(4):585\u201395.","journal-title":"Mol Cell"},{"issue":"4","key":"169_CR18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1097-2765(00)80211-7","volume":"4","author":"ED Rosen","year":"1999","unstructured":"Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 1999;4(4):611\u20137.","journal-title":"Mol Cell"},{"issue":"4","key":"169_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","volume":"47","author":"BM Spiegelman","year":"1998","unstructured":"Spiegelman BM. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes. 1998;47(4):507\u201314.","journal-title":"Diabetes"},{"issue":"3","key":"169_CR20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/01.ATV.19.3.546","volume":"19","author":"N Marx","year":"1999","unstructured":"Marx N, Bourcier T, Sukhova GK, Libby P, Plutzky J. PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol. 1999;19(3):546\u201351.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"169_CR21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/CIRCRESAHA.107.164384","volume":"102","author":"SZ Duan","year":"2008","unstructured":"Duan SZ, Usher MG, Mortensen RM. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Circ Res. 2008;102(3):283\u201394.","journal-title":"Circ Res"},{"issue":"23","key":"169_CR22","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000103683.99399.7E","volume":"108","author":"RW Nesto","year":"2003","unstructured":"Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Circulation. 2003;108(23):2941\u20138.","journal-title":"Circulation"},{"issue":"4","key":"169_CR23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bcp.2012.11.013","volume":"85","author":"T Sinagra","year":"2013","unstructured":"Sinagra T, Tamburella A, Urso V, Siarkos I, Drago F, Bucolo C, Salomone S. Reversible inhibition of vasoconstriction by thiazolidinediones related to PI3K\/Akt inhibition in vascular smooth muscle cells. Biochem Pharmacol. 2013;85(4):551\u20139.","journal-title":"Biochem Pharmacol"},{"issue":"48","key":"169_CR24","doi-asserted-by":"crossref","first-page":"46226","DOI":"10.1074\/jbc.M207776200","volume":"277","author":"D Prusty","year":"2002","unstructured":"Prusty D, Park BH, Davis KE, Farmer SR. Activation of MEK\/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma ) and C\/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem. 2002;277(48):46226\u201332.","journal-title":"J Biol Chem"},{"issue":"3","key":"169_CR25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2337\/diabetes.55.03.06.db05-0771","volume":"55","author":"K Naruse","year":"2006","unstructured":"Naruse K, Rask-Madsen C, Takahara N, Ha SW, Suzuma K, Way KJ, Jacobs JR, Clermont AC, Ueki K, Ohshiro Y, et al. Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. Diabetes. 2006;55(3):691\u20138.","journal-title":"Diabetes"},{"issue":"1","key":"169_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/ERC-09-0170","volume":"17","author":"M Luconi","year":"2010","unstructured":"Luconi M, Mangoni M, Gelmini S, Poli G, Nesi G, Francalanci M, Pratesi N, Cantini G, Lombardi A, Pepi M, et al. Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. Endocr Relat Cancer. 2010;17(1):169\u201377.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"169_CR27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11011-016-9791-4","volume":"31","author":"SS Patel","year":"2016","unstructured":"Patel SS, Gupta S, Udayabanu M. Urtica Dioica modulates hippocampal insulin signaling and recognition memory deficit in streptozotocin induced diabetic mice. Metab Brain Dis. 2016;31(3):601\u201311.","journal-title":"Metab Brain Dis"},{"issue":"52","key":"169_CR28","doi-asserted-by":"crossref","first-page":"22504","DOI":"10.1073\/pnas.0912487106","volume":"106","author":"S Sugii","year":"2009","unstructured":"Sugii S, Olson P, Sears DD, Saberi M, Atkins AR, Barish GD, Hong SH, Castro GL, Yin YQ, Nelson MC, et al. PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization. Proc Natl Acad Sci U S A. 2009;106(52):22504\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"169_CR29","doi-asserted-by":"crossref","first-page":"15712","DOI":"10.1073\/pnas.2536828100","volume":"100","author":"W He","year":"2003","unstructured":"He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A. 2003;100(26):15712\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"169_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1479-5876-11-241","volume":"11","author":"J Li","year":"2013","unstructured":"Li J, Davies BR, Han S, Zhou M, Bai Y, Zhang J, Xu Y, Tang L, Wang H, Liu YJ, et al. The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere. J Transl Med. 2013;11:241.","journal-title":"J Transl Med"},{"issue":"7","key":"169_CR31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4161\/cbt.9.7.11100","volume":"9","author":"C Cherrin","year":"2010","unstructured":"Cherrin C, Haskell K, Howell B, Jones R, Leander K, Robinson R, Watkins A, Bilodeau M, Hoffman J, Sanderson P, et al. An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo. Cancer Biol Ther. 2010;9(7):493\u2013503.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"169_CR32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.ATV.21.4.560","volume":"21","author":"M Inoue","year":"2001","unstructured":"Inoue M, Itoh H, Tanaka T, Chun TH, Doi K, Fukunaga Y, Sawada N, Yamshita J, Masatsugu K, Saito T, et al. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol. 2001;21(4):560\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"169_CR33","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.101.11.1311","volume":"101","author":"RE Law","year":"2000","unstructured":"Law RE, Goetze S, Xi XP, Jackson S, Kawano Y, Demer L, Fishbein MC, Meehan WP, Hsueh WA. Expression and function of PPARgamma in rat and human vascular smooth muscle cells. Circulation. 2000;101(11):1311\u20138.","journal-title":"Circulation"},{"key":"169_CR34","doi-asserted-by":"crossref","first-page":"943614","DOI":"10.1155\/2008\/943614","volume":"2008","author":"T Yang","year":"2008","unstructured":"Yang T, Soodvilai S. Renal and vascular mechanisms of thiazolidinedione-induced fluid retention. PPAR Res. 2008;2008:943614.","journal-title":"PPAR Res"},{"issue":"Suppl 1","key":"169_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-2005-861363","volume":"37","author":"MT Schram","year":"2005","unstructured":"Schram MT, Stehouwer CD. Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res. 2005;37(Suppl 1):49\u201355.","journal-title":"Horm Metab Res"},{"issue":"12","key":"169_CR36","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.4049\/jimmunol.164.12.6503","volume":"164","author":"N Marx","year":"2000","unstructured":"Marx N, Mach F, Sauty A, Leung JH, Sarafi MN, Ransohoff RM, Libby P, Plutzky J, Luster AD. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol. 2000;164(12):6503\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"169_CR37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.CIR.101.3.235","volume":"101","author":"V Pasceri","year":"2000","unstructured":"Pasceri V, Wu HD, Willerson JT, Yeh ET. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation. 2000;101(3):235\u20138.","journal-title":"Circulation"},{"issue":"9","key":"169_CR38","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.19.9.2094","volume":"19","author":"SM Jackson","year":"1999","unstructured":"Jackson SM, Parhami F, Xi XP, Berliner JA, Hsueh WA, Law RE, Demer LL. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol. 1999;19(9):2094\u2013104.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"169_CR39","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1006\/bbrc.1999.1437","volume":"263","author":"NG Chen","year":"1999","unstructured":"Chen NG, Sarabia SF, Malloy PJ, Zhao XY, Feldman D, Reaven GM. PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression. Biochem Biophys Res Commun. 1999;263(3):718\u201322.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"169_CR40","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0006-291X(02)00385-6","volume":"293","author":"S Goetze","year":"2002","unstructured":"Goetze S, Eilers F, Bungenstock A, Kintscher U, Stawowy P, Blaschke F, Graf K, Law RE, Fleck E, Grafe M. PPAR activators inhibit endothelial cell migration by targeting Akt. Biochem Biophys Res Commun. 2002;293(5):1431\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"169_CR41","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1074\/jbc.274.13.9116","volume":"274","author":"X Xin","year":"1999","unstructured":"Xin X, Yang S, Kowalski J, Gerritsen ME. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. J Biol Chem. 1999;274(13):9116\u201321.","journal-title":"J Biol Chem"},{"issue":"5","key":"169_CR42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archopht.119.5.709","volume":"119","author":"T Murata","year":"2001","unstructured":"Murata T, Hata Y, Ishibashi T, Kim S, Hsueh WA, Law RE, Hinton DR. Response of experimental retinal neovascularization to thiazolidinediones. Arch Ophthalmol. 2001;119(5):709\u201317.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"169_CR43","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jcp.24295","volume":"228","author":"M Terrasi","year":"2013","unstructured":"Terrasi M, Bazan V, Caruso S, Insalaco L, Amodeo V, Fanale D, Corsini LR, Contaldo C, Mercanti A, Fiorio E, et al. Effects of PPARgamma agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. J Cell Physiol. 2013;228(6):1368\u201374.","journal-title":"J Cell Physiol"},{"issue":"10","key":"169_CR44","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.2337\/db07-0069","volume":"56","author":"C Werner","year":"2007","unstructured":"Werner C, Kamani CH, Gensch C, Bohm M, Laufs U. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes. 2007;56(10):2609\u201315.","journal-title":"Diabetes"},{"issue":"4","key":"169_CR45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/86490","volume":"7","author":"FL Celletti","year":"2001","unstructured":"Celletti FL, Waugh JM, Amabile PG, Brendolan A, Hilfiker PR, Dake MD. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med. 2001;7(4):425\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"169_CR46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cardiores.2007.01.010","volume":"74","author":"V Chintalgattu","year":"2007","unstructured":"Chintalgattu V, Harris GS, Akula SM, Katwa LC. PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. Cardiovasc Res. 2007;74(1):140\u201350.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"169_CR47","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.bbrc.2006.07.133","volume":"348","author":"S Kanata","year":"2006","unstructured":"Kanata S, Akagi M, Nishimura S, Hayakawa S, Yoshida K, Sawamura T, Munakata H, Hamanishi C. Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-gamma. Biochem Biophys Res Commun. 2006;348(3):1003\u201310.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"169_CR48","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/mol.108.049395","volume":"74","author":"D Schiefelbein","year":"2008","unstructured":"Schiefelbein D, Seitz O, Goren I, Dissmann JP, Schmidt H, Bachmann M, Sader R, Geisslinger G, Pfeilschifter J, Frank S. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair. Mol Pharmacol. 2008;74(4):952\u201363.","journal-title":"Mol Pharmacol"},{"key":"169_CR49","doi-asserted-by":"crossref","first-page":"910783","DOI":"10.1155\/2009\/910783","volume":"2009","author":"C Whiteside","year":"2009","unstructured":"Whiteside C, Wang H, Xia L, Munk S, Goldberg HJ, Fantus IG. Rosiglitazone prevents high glucose-induced vascular endothelial growth factor and collagen IV expression in cultured mesangial cells. Exp Diabetes Res. 2009;2009:910783.","journal-title":"Exp Diabetes Res"},{"issue":"1","key":"169_CR50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00011-011-0386-6","volume":"61","author":"RT Mattos","year":"2012","unstructured":"Mattos RT, Bosco AA, Nogueira-Machado JA. Rosiglitazone, a PPAR-gamma agonist, inhibits VEGF secretion by peripheral blood mononuclear cells and ROS production by human leukocytes. Inflamm Res. 2012;61(1):37\u201341.","journal-title":"Inflamm Res"},{"issue":"11","key":"169_CR51","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ncb1486","volume":"8","author":"J Gavard","year":"2006","unstructured":"Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 2006;8(11):1223\u201334.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"169_CR52","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.phrs.2010.03.002","volume":"61","author":"N Ogasawara","year":"2010","unstructured":"Ogasawara N, Kojima T, Go M, Ohkuni T, Koizumi J, Kamekura R, Masaki T, Murata M, Tanaka S, Fuchimoto J, et al. PPARgamma agonists upregulate the barrier function of tight junctions via a PKC pathway in human nasal epithelial cells. Pharmacol Res. 2010;61(6):489\u201398.","journal-title":"Pharmacol Res"},{"issue":"5","key":"169_CR53","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1096\/fj.08-121624","volume":"23","author":"W Huang","year":"2009","unstructured":"Huang W, Eum SY, Andras IE, Hennig B, Toborek M. PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J. 2009;23(5):1596\u2013606.","journal-title":"FASEB J"},{"issue":"8","key":"169_CR54","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.RES.86.8.892","volume":"86","author":"M Morales-Ruiz","year":"2000","unstructured":"Morales-Ruiz M, Fulton D, Sowa G, Languino LR, Fujio Y, Walsh K, Sessa WC. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine\/threonine kinase Akt. Circ Res. 2000;86(8):892\u20136.","journal-title":"Circ Res"},{"issue":"7","key":"169_CR55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1139\/Y09-040","volume":"87","author":"J Wu","year":"2009","unstructured":"Wu J, Lei MX, Xie XY, Liu L, She YM, Mo J, Wang S. Rosiglitazone inhibits high glucose-induced apoptosis in human umbilical vein endothelial cells through the PI3K\/Akt\/eNOS pathway. Can J Physiol Pharmacol. 2009;87(7):549\u201355.","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"169_CR56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1254\/jphs.11149FP","volume":"117","author":"S Xu","year":"2011","unstructured":"Xu S, Zhao Y, Yu L, Shen X, Ding F, Fu G. Rosiglitazone attenuates endothelial progenitor cell apoptosis induced by TNF-alpha via ERK\/MAPK and NF-kappaB signal pathways. J Pharmacol Sci. 2011;117(4):265\u201374.","journal-title":"J Pharmacol Sci"},{"issue":"4","key":"169_CR57","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/ATVBAHA.107.160713","volume":"28","author":"A Lombardi","year":"2008","unstructured":"Lombardi A, Cantini G, Piscitelli E, Gelmini S, Francalanci M, Mello T, Ceni E, Varano G, Forti G, Rotondi M, et al. A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells. Arterioscler Thromb Vasc Biol. 2008;28(4):718\u201324.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"169_CR58","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","volume":"9","author":"R Seger","year":"1995","unstructured":"Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995;9(9):726\u201335.","journal-title":"FASEB J"},{"issue":"4","key":"169_CR59","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCRESAHA.113.301074","volume":"113","author":"Q Li","year":"2013","unstructured":"Li Q, Park K, Li C, Rask-Madsen C, Mima A, Qi W, Mizutani K, Huang P, King GL. Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C-beta isoform in the endothelium. Circ Res. 2013;113(4):418\u201327.","journal-title":"Circ Res"},{"issue":"1","key":"169_CR60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/CIRCULATIONAHA.112.127514","volume":"127","author":"CE Tabit","year":"2013","unstructured":"Tabit CE, Shenouda SM, Holbrook M, Fetterman JL, Kiani S, Frame AA, Kluge MA, Held A, Dohadwala MM, Gokce N, et al. Protein kinase C-beta contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation. 2013;127(1):86\u201395.","journal-title":"Circulation"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-017-0169-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T15:38:46Z","timestamp":1719416326000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-017-0169-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["169"],"URL":"https:\/\/doi.org\/10.1186\/s40360-017-0169-y","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]},"article-number":"62"}}